WindRose Health Investors acquires CardioOne

WindRose Health Investors, LLC announced that it has completed the acquisition of CardioOne Inc.. The terms of the transaction were not disclosed.

WindRose partnered with CardioOne’s executive team to acquire the business and to provide up to $100 million of additional capital to support the Company’s ongoing growth. With WindRose’s investment, CardioOne will accelerate its next phase of expansion and enhance its existing service offerings. CardioOne’s current management team will continue to lead the company and remain active shareholders going forward.

“We are excited for the opportunity to partner with WindRose as CardioOne embarks on its next chapter of growth,” said Jasen Gundersen MD, CardioOne’s Chief Executive Officer and co-founder. “We believe that working with WindRose, which has a history of successfully partnering with companies to help navigate the transition to value-based care, will empower us to continue supporting independent cardiologists while developing additional solutions that maximize each practice’s potential in the shift to VBC arrangements.”

“CardioOne’s unique, physician-aligned model meets the market where it is and positions the Company to take advantage of the growing desire among cardiologists to maintain their independence,” said Oliver Moses, Managing Partner with WindRose. “We believe CardioOne delivers a compelling tech-enabled offering to the independent cardiology market and has significant growth potential as the Company builds upon its momentum in 2023. We are excited to join forces with Jasen and his team as they continue to build upon the differentiated platform they have created.”

McDermott Will & Emery LLP and Bass, Berry & Sims PLC acted as legal advisors to WindRose and Kastner Gravelle LLP acted as legal advisor to CardioOne.
MB Bureau